Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors

Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors

US Patent 11702472 · Granted Jul 18, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) a2025
Transgenic T cell and chimeric antigen receptor T cell compositions and related 2025
Compositions and methods for treating cancer with anti-CD38 immunotherapy2025
ADAM17 binding molecules and uses thereof2025
Cancer antigen targets and uses thereof2025
Chimeric receptors targeting ADGRE2 and/or CLEC12A and uses thereof2025
Compositions and methods for immunotherapy2025
Compositions and methods for immunotherapy2025
Cancer antigen targets and uses thereof2025
Virtual machine file management using file-level snapshots2025
Immune cell compositions and methods of use2024
Immune cell compositions and methods of use2024